Wellgistics Converts $2M Compensation into 10M Shares, 10M Warrants at $0.01
Wellgistics Health's CEO and a director converted $2.0 million of accrued compensation into 10 million common shares at $0.20 per share, representing a premium to trading price. The company also issued 10 million warrants exercisable at $0.01 for five years and imposed a six-month lock-up on the newly issued shares.
1. Conversion Details
Prashant Patel, CEO, and a board member converted about $2.0 million of accrued compensation into approximately 10 million shares of common stock at $0.20 per share, representing a premium to trading price and reducing deferred liabilities on the balance sheet.
2. Warrant Terms
As additional consideration, the company issued 10 million warrants to purchase common stock at $0.01 per share, exercisable immediately with a five-year term and subject to customary anti-dilution adjustments.
3. Lock-Up and Strategic Rationale
The newly issued shares are subject to a six-month transfer restriction under a lock-up agreement, and the transaction was approved by disinterested directors to align management incentives with long-term shareholder value.